Fertility and Sterility

Papers
(The H4-Index of Fertility and Sterility is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Progestin induced depression in endometriosis237
A commentary on risk of multiple live births across sexual orientation groups accessing medically assisted reproduction179
Fresh embryo transfer after in vitro insemination of fresh vs. cryopreserved anonymous donor oocytes: which has a better live birth rate? A Society for Assisted Reproductive Technology Clinic Outcome 141
Antibody-dependent complement-mediated sperm cytotoxicity in the endocervix is a dominant contraceptive mechanism of ZB-06 vaginal film141
Azoospermia factor c microdeletions and outcomes of assisted reproductive technology: a systematic review and meta-analysis125
Optimization of peritoneal fluid and leukocyte collection in patients with endometriosis121
Editorial Board104
Trends and outcomes of fresh and frozen donor oocyte cycles in the United States101
Association between embryo morphological quality and birth weight for singletons conceived via autologous fresh embryo transfer: an analysis using Society for Assisted Reproductive Technology Clinical100
Coronavirus disease 2019, reproductive health, and public policy: lessons learned after two years of the ongoing pandemic—the American Society for Reproductive Medicine’s Center for Policy and Leaders99
An investigation of racial and ethnic disparities in donor sperm availability in the United States93
ARTIFICIAL INTELLIGENCE TO LEVEL THE NUMBER OF VAGINAL OOCYTE RETRIEVALS PER DAY AT A SINGLE CLINIC93
NOVEL FOLLICLE-STIMULATING HORMONE RECEPTOR MUTATIONS CAUSING OVARIAN DYSGENESIS AND PRIMARY OVARIAN INSUFFICIENCY83
SIMPLE VERSUS COMPLEX CONGENITAL UTERINE ANOMALY (CUA) REPAIR: ARE THE OUTCOMES SIMILAR?83
ASSOCIATION BETWEEN SOCIOECONOMIC DEPRIVATION, LIFE EXPECTANCY AND SERUM AMH LEVELS IN A COHORT OF INFERTILE WOMEN80
VITRIFICATION OF HUMAN TESTICULAR AND EPIDIDYMAL SPERMATOZOA WITHOUT PERMEABLE CRYOPROTECTANTS: CLINICAL OUTCOMES78
MODE OF DELIVERY IMPACTS SUBSEQUENT PREGNANCY ATTEMPTS IN PATIENTS RETURNING FOR SINGLE, EUPLOID FET USING THE SAME EMBRYO COHORT75
AMBIENT AIR POLLUTION AND FECUNDABILITY IN A PRECONCEPTION TIME-TO-PREGNANCY COHORT74
RESIDENTIAL AIR POLLUTION LEVELS DO NOT APPEAR TO AFFECT EMBRYOLOGY OUTCOMES IN PATIENTS UNDERGOING IN VITRO FERTILIZATION (IVF): INSIGHTS FROM 5,687 CYCLES CONDUCTED IN NEW JERSEY FROM 2020 TO 202373
ANALYSIS OF MULTI-OMICS BIOMARKERS IN EJACULATES OF YOUNG ADULTS69
“EVERYBODY WOULD LISTEN– THEY’D HAVE SUPER BIONIC EARS”: BLACK WOMEN’S PERSPECTIVES ON UTOPIC ART CARE65
DELAY OF CARE NEGATIVELY IMPACTS FEMALE PARTNERS OF PATIENTS WITH MALE FACTOR INFERTILITY64
ACCESS TO, AND USE OF, FERTILITY PRESERVATION SERVICES AMONG TRANSGENDER INDIVIDUALS64
USING THE BINOMIAL THEOREM TO PREDICT THE DISTRIBUTION OF NORMAL EUPLOID BLASTOCYSTS WITHIN A COHORT SIMPLY BASEDUPON THE COHORT’S DISCRETE SIZE64
TRANSVAGINAL MYOLYSIS: PRELIMINARY DATA FROM A LARGE TERTIARY CENTER REGISTRY62
ENGLISH AS A SECOND LANGUAGE WITHIN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) TREATMENT61
MULTIPLE GESTATION PREGNANCY RATES AFTER ULTRASOUND MONITORED VS OVULATION PREDICTOR KIT MONITORED OVULATION STIMULATION-INTRAUTERINE INSEMINATION CYCLES61
RELATING TO THE PREVALENCE OF DEPRESSION SYMPTOMS IN INFERTILE WOMEN AND SOCIAL, PSYCHOLOGICAL CHARACTERISTICS59
A NOVEL APPROACH TO ASSESSING EMBRYO QUALITY IN ASSISTED REPRODUCTIVE TECHNOLOGY: DNA METHYLATION59
PREDICTING IVF LIVE BIRTH PROBABILITIES USING MACHINE LEARNING, CENTER-SPECIFIC AND NATIONAL REGISTRY-BASED MODELS59
CONSUMPTION OF ULTRA-PROCESSED FOODS IS NOT ASSOCIATED WITH FEMALE INFERTILITY: A CROSS-SECTIONAL STUDY OF THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), 2013-201858
TWO-STEP DOUBLE TRANSFER OF GENETICALLY TESTED EMBRYOS IN PATIENTS WITH IMPLANTATION FAILURE57
WEIGHT LOSS FOR PCOS: HOW MUCH WEIGHT SHOULD WE GIVE THE INFORMATION WE SEE ON TIKTOK?55
THE RISK OF BIRTH DEFECTS IDENTIFIED DURING THE FIRST YEAR OF LIFE IS NOT ASSOCIATED WITH GRADE OF BLASTOCYST MORPHOLOGY AMONG CHILDREN CONCEIVED WITH IN VITRO FERTILIZATION (IVF)55
EXAMINING HYPERTENSION AT OOCYTE RETRIEVAL AS A PREDICTOR OF PREECLAMPSIA RISK IN PREGNANCIES CONCEIVED THROUGH IN-VITRO FERTILIZATION55
THE ASSOCIATION OF MITOCHONDRIAL DNA (mtDNA) PROPORTION IN TROPHOBLAST CELLS WITH THE IMPLANTATION OUTCOME OF EMBRYO TRANSFER54
GONADOTROPIN USAGE AMONG OOCYTE CRYOPRESERVATION CYCLES: DOES THE LIMIT EXIST?52
SURROGACY: PRACTICES, CHALLENGES, GLOBAL STANDARDS-INSIGHT FROM NURSING PROFESSIONALS52
THE IMPACT OF VITAMIN D DEFICIENCY ON RESPONSE TO LETROZOLE OVULATION INDUCTION IN PATIENTS WITH PCOS51
RISK OF MISINTERPRETATION OF HAPLOBLOCK OF KARYOMAPPING FOR PGT-M WHEN ANEUPLOIDY OR MOSAICISM OCCURS IN THE CHROMOSOME CONTAINING TARGET GENE51
EFFECT OF PROLONGED OOCYTE CRYOPRESERVATION ON FERTILIZATION AND PREGNANCY OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS50
IMAGING MASS CYTOMETRY FOR ASSESSMENT OF THE ENDOMETRIAL IMMUNE MICROENVIRONMENT IN ASHERMAN SYNDROME: A FEASIBILITY STUDY50
HIGH ANXIETY IS POSITIVELY ASSOCIATED WITH SEXUAL DYSFUNCTION AMONG MEN UNDERGOING FERTILITY TESTING50
OOCYTE ASSESSMENT BASED ON ARTIFICIAL INTELLIGENCE (AI) FOR THE PREDICTION OF BLASTOCYST DEVELOPMENT: A COMPARATIVE ANALYSIS OF FRESH AND VITRIFIED DONOR OOCYTES50
PRE-TRANSFER ENDOMETRIAL GROWTH AND BLASTOCYST TROPHECTODERM MEASUREMENT CORRELATE WITH BIRTH WEIGHT AFTER CONTROLLING FOR GESTATIONAL AGE, BODY MASS INDEX, AND INFANT SEX49
RECURRENT EUPLOID IMPLANTATION FAILURE PREVALENCE AND CLINICAL RISK FACTORS: A SART CORS ANALYSIS49
THE IMPACT OF NON-MALE FACTOR INTRACYTOPLASMIC SPERM INJECTION (ICSI) ON FERTILITY OUTCOMES IN OVERWEIGHT AND OBESE WOMEN49
What are my options? Fertility preservation methods for young girls and women48
HIGHER DOSE GONADOTROPINS DO NOT IMPROVE CLINICAL OUTCOMES IN POOR PROGNOSIS PATIENTS: RESULTS OF A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (RCT)48
0.44768691062927